Aradigm Corporation Stock OTC Bulletin Board
Equities
Biotechnology & Medical Research
Financials (USD)
Sales 2016 | 195K | Sales 2017 | 14.46M | Capitalization | 97.3M |
---|---|---|---|---|---|
Net income 2016 | -32M | Net income 2017 | -10M | EV / Sales 2016 | 73.3 x |
Net cash position 2016 | 9.37M | Net Debt 2017 | 7.91M | EV / Sales 2017 | 7.27 x |
P/E ratio 2016 |
-0.72
x | P/E ratio 2017 |
-9.3
x | Employees | - |
Yield 2016 * |
-
| Yield 2017 |
-
| Free-Float | 60.28% |
1st Jan change | Capi. | |
---|---|---|
+29.03% | 48.16B | |
-0.10% | 41.73B | |
+43.45% | 41.03B | |
-5.26% | 28.77B | |
+11.48% | 25.59B | |
-22.74% | 18.96B | |
+9.06% | 12.92B | |
+30.01% | 12.03B | |
-1.51% | 11.77B |